Tuesday, July 16, 2024
Outlook India
Outlook Business

Janus Henderson

Prior to this, Blackrock slashed its valuation to $11 billion in February

The late-stage investment focussed firm slashed the edtech company’s valuation by nine per cent to $2.9 billion

The development came four months after the Drug Controller General of India (DGCI) show caused multiple online pharmacy platforms over the violation of norms regarding the online sale of drugs

Prior to this, Baron Capital lowered the company’s valuation to $6.7 billion as of June 2022.

Prior to this, Neuberger Berman, a New York-based investment management firm slashed PharmEasy’s valuation by 21 per cent to 4.4 billion as of February 28